ANB-002 / Biocad - LARVOL DELTA

MAGNOLIA: An Open-Label, Comparative Study of the Efficacy, Safety and Pharmacodynamics of Single Dose of ANB-002 in Patients With Hemophilia B (clinicaltrials.gov) - P3 | N=24 | Recruiting | Sponsor: Biocad | Not yet recruiting ➔ Recruiting

Enrollment open • Hematological Disorders • Hemophilia • Hemophilia B • Rare Diseases

Study of the Safety, Pharmacodynamics and Efficacy of ANB-002 in Patients With Hemophilia B (SAFRAN) (clinicaltrials.gov) - P1/2 | N=28 | Recruiting | Sponsor: Biocad | N=12 ➔ 28

Enrollment change • Hematological Disorders • Hemophilia • Hemophilia B • Rare Diseases

MAGNOLIA: An Open-Label, Comparative Study of the Efficacy, Safety and Pharmacodynamics of Single Dose of ANB-002 in Patients with Hemophilia B (clinicaltrials.gov) - P3 | N=24 | Not yet recruiting | Sponsor: Biocad

New P3 trial • Hematological Disorders • Hemophilia • Hemophilia B • Rare Diseases